Saunders, Laura C.;
Hughes, Paul J. C.;
Alabed, Samer;
Capener, David J.;
Marshall, Helen;
Vogel‐Claussen, Jens;
van Beek, Edwin J. R.;
Kiely, David G.;
Swift, Andrew J.;
Wild, Jim M.
Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension
Contributor:
Saunders, Laura C.;
Hughes, Paul J. C.;
Alabed, Samer;
Capener, David J.;
Marshall, Helen;
Vogel‐Claussen, Jens;
van Beek, Edwin J. R.;
Kiely, David G.;
Swift, Andrew J.;
Wild, Jim M.
Published:
Wiley, 2022
Published in:
Journal of Magnetic Resonance Imaging, 55 (2022) 3, Seite 633-652
Language:
English
DOI:
10.1002/jmri.27849
ISSN:
1053-1807;
1522-2586
Origination:
Footnote:
Description:
Pulmonary hypertension (PH) is a heterogeneous condition that can affect the lung parenchyma, pulmonary vasculature, and cardiac chambers. Accurate diagnosis often requires multiple complex assessments of the cardiac and pulmonary systems. MRI is able to comprehensively assess cardiac structure and function, as well as lung parenchymal, pulmonary vascular, and functional lung changes. Therefore, MRI has the potential to provide an integrated functional and structural assessment of the cardiopulmonary system in a single exam. Cardiac MRI is used in the assessment of PH in most large PH centers, whereas lung MRI is an emerging technique in patients with PH. This article reviews the current literature on cardiopulmonary MRI in PH, including cine MRI, black‐blood imaging, late gadolinium enhancement, T1 mapping, myocardial strain analysis, contrast‐enhanced perfusion imaging and contrast‐enhanced MR angiography, and hyperpolarized gas functional lung imaging. This article also highlights recent developments in this field and areas of interest for future research including cardiac MRI‐based diagnostic models, machine learning in cardiac MRI, oxygen‐enhanced 1H imaging, contrast‐free 1H perfusion and ventilation imaging, contrast‐free angiography and UTE imaging.Evidence Level5Technical EfficacyStage 3